<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34172817</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2399-3642</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>25</Day></PubDate></JournalIssue><Title>Communications biology</Title><ISOAbbreviation>Commun Biol</ISOAbbreviation></Journal><ArticleTitle>Reduced C9orf72 function leads to defective synaptic vesicle release and neuromuscular dysfunction in zebrafish.</ArticleTitle><Pagination><StartPage>792</StartPage><MedlinePgn>792</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">792</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s42003-021-02302-y</ELocationID><Abstract><AbstractText>The most common genetic cause of amyotrophic lateral sclerosis (ALS) and fronto-temporal dementia (FTD) is a hexanucleotide repeat expansion within the C9orf72 gene. Reduced levels of C9orf72 mRNA and protein have been found in ALS/FTD patients, but the role of this protein in disease pathogenesis is still poorly understood. Here, we report the generation and characterization of a stable C9orf72 loss-of-function (LOF) model in the zebrafish. We show that reduced C9orf72 function leads to motor defects, muscle atrophy, motor neuron loss and mortality in early larval and adult stages. Analysis of the structure and function of the neuromuscular junctions (NMJs) of the larvae, reveal a marked reduction in the number of presynaptic and postsynaptic structures and an impaired release of quantal synaptic vesicles at the NMJ. Strikingly, we demonstrate a downregulation of SV2a upon C9orf72-LOF and a reduced rate of synaptic vesicle cycling. Furthermore, we show a reduced number and size of Rab3a-postive synaptic puncta at NMJs. Altogether, these results reveal a key function for C9orf72 in the control of presynaptic vesicle trafficking and release at the zebrafish larval NMJ. Our study demonstrates an important role for C9orf72 in ALS/FTD pathogenesis, where it regulates synaptic vesicle release and neuromuscular functions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Butti</LastName><ForeName>Zo&#xe9;</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>INRS- Centre Armand-Frappier Sant&#xe9; Biotechnologie, Laval, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Yingzhou Edward</ForeName><Initials>YE</Initials><AffiliationInfo><Affiliation>INRS- Centre Armand-Frappier Sant&#xe9; Biotechnologie, Laval, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giacomotto</LastName><ForeName>Jean</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Queensland Brain Institute, University of Queensland, St Lucia, QLD, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Queensland Centre for Mental Health Research, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patten</LastName><ForeName>Shunmoogum A</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0002-2782-3547</Identifier><AffiliationInfo><Affiliation>INRS- Centre Armand-Frappier Sant&#xe9; Biotechnologie, Laval, QC, Canada. kessen.patten@inrs.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre d'Excellence en Recherche sur les Maladies Orphelines - Fondation Courtois (CERMO-FC), Universit&#xe9; du Qu&#xe9;bec &#xe0; Montr&#xe9;al (UQAM), Montr&#xe9;al, QC, Canada. kessen.patten@inrs.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Commun Biol</MedlineTA><NlmUniqueID>101719179</NlmUniqueID><ISSNLinking>2399-3642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020511" MajorTopicYN="N">Neuromuscular Junction Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013572" MajorTopicYN="N">Synaptic Vesicles</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015027" MajorTopicYN="N">Zebrafish</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34172817</ArticleId><ArticleId IdType="pmc">PMC8233344</ArticleId><ArticleId IdType="doi">10.1038/s42003-021-02302-y</ArticleId><ArticleId IdType="pii">10.1038/s42003-021-02302-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>DeJesus-Hernandez M, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T, et al. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc. Natl Acad. Sci. USA. 2013;110:E4968&#x2013;E4977. doi: 10.1073/pnas.1315438110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1315438110</ArticleId><ArticleId IdType="pmc">PMC3870665</ArticleId><ArticleId IdType="pubmed">24248382</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash PE, et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron. 2013;77:639&#x2013;646. doi: 10.1016/j.neuron.2013.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.004</ArticleId><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, et al. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol. 2013;126:881&#x2013;893. doi: 10.1007/s00401-013-1189-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1189-3</ArticleId><ArticleId IdType="pubmed">24132570</ArticleId></ArticleIdList></Reference><Reference><Citation>Belzil VV, et al. Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood. Acta Neuropathol. 2013;126:895&#x2013;905. doi: 10.1007/s00401-013-1199-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1199-1</ArticleId><ArticleId IdType="pmc">PMC3830740</ArticleId><ArticleId IdType="pubmed">24166615</ArticleId></ArticleIdList></Reference><Reference><Citation>Frick P, et al. Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers. Acta Neuropathol. Commun. 2018;6:72. doi: 10.1186/s40478-018-0579-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0579-0</ArticleId><ArticleId IdType="pmc">PMC6091050</ArticleId><ArticleId IdType="pubmed">30075745</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Isaacs AM. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat. Rev. Neurol. 2018;14:544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan PM, et al. The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway. Acta Neuropathol. Commun. 2016;4:51. doi: 10.1186/s40478-016-0324-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0324-5</ArticleId><ArticleId IdType="pmc">PMC4870812</ArticleId><ArticleId IdType="pubmed">27193190</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbier C, Sellier C. C9ORF72 is a GDP/GTP exchange factor for Rab8 and Rab39 and regulates autophagy. Small GTPases. 2017;8:181&#x2013;186. doi: 10.1080/21541248.2016.1212688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21541248.2016.1212688</ArticleId><ArticleId IdType="pmc">PMC5584738</ArticleId><ArticleId IdType="pubmed">27494456</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugolino J, et al. Loss of C9orf72 enhances autophagic activity via deregulated mTOR and TFEB signaling. PLoS Genet. 2016;12:e1006443. doi: 10.1371/journal.pgen.1006443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1006443</ArticleId><ArticleId IdType="pmc">PMC5119725</ArticleId><ArticleId IdType="pubmed">27875531</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M, et al. A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy. Sci. Adv. 2016;2:e1601167. doi: 10.1126/sciadv.1601167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1601167</ArticleId><ArticleId IdType="pmc">PMC5010369</ArticleId><ArticleId IdType="pubmed">27617292</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellier C, et al. Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death. EMBO J. 2016;35:1276&#x2013;1297. doi: 10.15252/embj.201593350.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201593350</ArticleId><ArticleId IdType="pmc">PMC4910533</ArticleId><ArticleId IdType="pubmed">27103069</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, et al. The C9orf72-interacting protein Smcr8 is a negative regulator of autoimmunity and lysosomal exocytosis. Genes Dev. 2018;32:929&#x2013;943. doi: 10.1101/gad.313932.118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.313932.118</ArticleId><ArticleId IdType="pmc">PMC6075033</ArticleId><ArticleId IdType="pubmed">29950492</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat. Med. 2018;24:313&#x2013;325. doi: 10.1038/nm.4490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4490</ArticleId><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao S, McKeever PM, Lau A, Robertson J. Synaptic localization of C9orf72 regulates post-synaptic glutamate receptor 1 levels. Acta Neuropathol. Commun. 2019;7:161. doi: 10.1186/s40478-019-0812-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0812-5</ArticleId><ArticleId IdType="pmc">PMC6813971</ArticleId><ArticleId IdType="pubmed">31651360</ArticleId></ArticleIdList></Reference><Reference><Citation>Maselli RA, et al. Neuromuscular transmission in amyotrophic lateral sclerosis. Muscle Nerve. 1993;16:1193&#x2013;1203. doi: 10.1002/mus.880161109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880161109</ArticleId><ArticleId IdType="pubmed">8105377</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 2004;185:232&#x2013;240. doi: 10.1016/j.expneurol.2003.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey D, et al. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J. Neurosci. 2000;20:2534&#x2013;2542. doi: 10.1523/JNEUROSCI.20-07-02534.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-07-02534.2000</ArticleId><ArticleId IdType="pmc">PMC6772256</ArticleId><ArticleId IdType="pubmed">10729333</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray LM, Talbot K, Gillingwater TH. Review: neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy. Neuropathol. Appl. Neurobiol. 2010;36:133&#x2013;156. doi: 10.1111/j.1365-2990.2010.01061.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.2010.01061.x</ArticleId><ArticleId IdType="pubmed">20202121</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong GA, Drapeau P. Calcium channel agonists protect against neuromuscular dysfunction in a genetic model of TDP-43 mutation in ALS. J. Neurosci. 2013;33:1741&#x2013;1752. doi: 10.1523/JNEUROSCI.4003-12.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4003-12.2013</ArticleId><ArticleId IdType="pmc">PMC6618732</ArticleId><ArticleId IdType="pubmed">23345247</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong GA, Drapeau P. Loss and gain of FUS function impair neuromuscular synaptic transmission in a genetic model of ALS. Hum. Mol. Genet. 2013;22:4282&#x2013;4292. doi: 10.1093/hmg/ddt278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt278</ArticleId><ArticleId IdType="pubmed">23771027</ArticleId></ArticleIdList></Reference><Reference><Citation>Patten, S. A. et al. Neuroleptics as therapeutic compounds stabilizing neuromuscular transmission in amyotrophic lateral sclerosis. JCI Insight2, e97152 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5752378</ArticleId><ArticleId IdType="pubmed">29202456</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacomotto J, Rinkwitz S, Becker TS. Effective heritable gene knockdown in zebrafish using synthetic microRNAs. Nat. Commun. 2015;6:7378. doi: 10.1038/ncomms8378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms8378</ArticleId><ArticleId IdType="pmc">PMC4468906</ArticleId><ArticleId IdType="pubmed">26051838</ArticleId></ArticleIdList></Reference><Reference><Citation>Leong IU, Lan CC, Skinner JR, Shelling AN, Love DR. In vivo testing of microRNA-mediated gene knockdown in zebrafish. J. Biomed. Biotechnol. 2012;2012:350352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3303736</ArticleId><ArticleId IdType="pubmed">22500088</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawakami K, Shima A, Kawakami N. Identification of a functional transposase of the Tol2 element, an Ac-like element from the Japanese medaka fish, and its transposition in the zebrafish germ lineage. Proc. Natl Acad. Sci. USA. 2000;97:11403&#x2013;11408. doi: 10.1073/pnas.97.21.11403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.97.21.11403</ArticleId><ArticleId IdType="pmc">PMC17212</ArticleId><ArticleId IdType="pubmed">11027340</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw MP, et al. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features. Acta Neuropathol. Commun. 2018;6:125. doi: 10.1186/s40478-018-0629-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0629-7</ArticleId><ArticleId IdType="pmc">PMC6240957</ArticleId><ArticleId IdType="pubmed">30454072</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Costa MM, et al. A new zebrafish model produced by TILLING of SOD1-related amyotrophic lateral sclerosis replicates key features of the disease and represents a tool for in vivo therapeutic screening. Dis. Model Mech. 2014;7:73&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3882050</ArticleId><ArticleId IdType="pubmed">24092880</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakowski SA, et al. Neuromuscular effects of G93A-SOD1 expression in zebrafish. Mol. Neurodegeneration. 2012;7:44. doi: 10.1186/1750-1326-7-44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-7-44</ArticleId><ArticleId IdType="pmc">PMC3506515</ArticleId><ArticleId IdType="pubmed">22938571</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori F, et al. Phosphorylated TDP-43 aggregates in skeletal and cardiac muscle are a marker of myogenic degeneration in amyotrophic lateral sclerosis and various conditions. Acta Neuropathol. Commun. 2019;7:165. doi: 10.1186/s40478-019-0824-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0824-1</ArticleId><ArticleId IdType="pmc">PMC6816170</ArticleId><ArticleId IdType="pubmed">31661037</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmid B, et al. Loss of ALS-associated TDP-43 in zebrafish causes muscle degeneration, vascular dysfunction, and reduced motor neuron axon outgrowth. Proc. Natl Acad. Sci. USA. 2013;110:4986&#x2013;4991. doi: 10.1073/pnas.1218311110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1218311110</ArticleId><ArticleId IdType="pmc">PMC3612625</ArticleId><ArticleId IdType="pubmed">23457265</ArticleId></ArticleIdList></Reference><Reference><Citation>McLean DL, Fan J, Higashijima S, Hale ME, Fetcho JR. A topographic map of recruitment in spinal cord. Nature. 2007;446:71&#x2013;75. doi: 10.1038/nature05588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05588</ArticleId><ArticleId IdType="pubmed">17330042</ArticleId></ArticleIdList></Reference><Reference><Citation>Menelaou E, McLean DL. A gradient in endogenous rhythmicity and oscillatory drive matches recruitment order in an axial motor pool. J. Neurosci. 2012;32:10925&#x2013;10939. doi: 10.1523/JNEUROSCI.1809-12.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1809-12.2012</ArticleId><ArticleId IdType="pmc">PMC3428065</ArticleId><ArticleId IdType="pubmed">22875927</ArticleId></ArticleIdList></Reference><Reference><Citation>Roselli F, Caroni P. Modeling neuronal vulnerability in ALS. Neuron. 2014;83:758&#x2013;760. doi: 10.1016/j.neuron.2014.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.08.010</ArticleId><ArticleId IdType="pubmed">25144872</ArticleId></ArticleIdList></Reference><Reference><Citation>Winton MJ, et al. Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J. Biol. Chem. 2008;283:13302&#x2013;13309. doi: 10.1074/jbc.M800342200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M800342200</ArticleId><ArticleId IdType="pmc">PMC2442318</ArticleId><ArticleId IdType="pubmed">18305110</ArticleId></ArticleIdList></Reference><Reference><Citation>Geser F, et al. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch. Neurol. 2008;65:636&#x2013;641. doi: 10.1001/archneur.65.5.636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.65.5.636</ArticleId><ArticleId IdType="pubmed">18474740</ArticleId></ArticleIdList></Reference><Reference><Citation>Velebit J, et al. Astrocytes with TDP-43 inclusions exhibit reduced noradrenergic cAMP and Ca(2+) signaling and dysregulated cell metabolism. Sci. Rep. 2020;10:6003. doi: 10.1038/s41598-020-62864-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-62864-5</ArticleId><ArticleId IdType="pmc">PMC7138839</ArticleId><ArticleId IdType="pubmed">32265469</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen BK, et al. Synaptic dysfunction induced by glycine-alanine dipeptides in C9orf72-ALS/FTD is rescued by SV2 replenishment. EMBO Mol. Med. 2020;12:e10722. doi: 10.15252/emmm.201910722.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201910722</ArticleId><ArticleId IdType="pmc">PMC7207170</ArticleId><ArticleId IdType="pubmed">32347002</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei C, et al. miR-153 regulates SNAP-25, synaptic transmission, and neuronal development. PLoS ONE. 2013;8:e57080. doi: 10.1371/journal.pone.0057080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0057080</ArticleId><ArticleId IdType="pmc">PMC3581580</ArticleId><ArticleId IdType="pubmed">23451149</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Ono F, Brehm P. Optical measurements of presynaptic release in mutant zebrafish lacking postsynaptic receptors. J. Neurosci. 2003;23:10467&#x2013;10474. doi: 10.1523/JNEUROSCI.23-33-10467.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-33-10467.2003</ArticleId><ArticleId IdType="pmc">PMC6740929</ArticleId><ArticleId IdType="pubmed">14627630</ArticleId></ArticleIdList></Reference><Reference><Citation>Therrien M, Rouleau GA, Dion PA, Parker JA. Deletion of C9ORF72 results in motor neuron degeneration and stress sensitivity in C. elegans. PLoS ONE. 2013;8:e83450. doi: 10.1371/journal.pone.0083450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0083450</ArticleId><ArticleId IdType="pmc">PMC3861484</ArticleId><ArticleId IdType="pubmed">24349511</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciura S, et al. Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis. Ann. Neurol. 2013;74:180&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">23720273</ArticleId></ArticleIdList></Reference><Reference><Citation>Atanasio A, et al. C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice. Sci. Rep. 2016;6:23204. doi: 10.1038/srep23204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23204</ArticleId><ArticleId IdType="pmc">PMC4793236</ArticleId><ArticleId IdType="pubmed">26979938</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudria-Lopez E, et al. Full ablation of C9orf72 in mice causes immune system-related pathology and neoplastic events but no motor neuron defects. Acta Neuropathol. 2016;132:145&#x2013;147. doi: 10.1007/s00401-016-1581-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1581-x</ArticleId><ArticleId IdType="pmc">PMC4911370</ArticleId><ArticleId IdType="pubmed">27206760</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppers M, et al. C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits. Ann. Neurol. 2015;78:426&#x2013;438. doi: 10.1002/ana.24453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24453</ArticleId><ArticleId IdType="pmc">PMC4744979</ArticleId><ArticleId IdType="pubmed">26044557</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao Q, et al. C9orf72 deficiency promotes motor deficits of a C9ALS/FTD mouse model in a dose-dependent manner. Acta Neuropathol. Commun. 2019;7:32. doi: 10.1186/s40478-019-0685-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0685-7</ArticleId><ArticleId IdType="pmc">PMC6398253</ArticleId><ArticleId IdType="pubmed">30832726</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong W, et al. Knock in of a hexanucleotide repeat expansion in the C9orf72 gene induces ALS in rats. Anim. Model Exp. Med. 2020;3:237&#x2013;244. doi: 10.1002/ame2.12129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ame2.12129</ArticleId><ArticleId IdType="pmc">PMC7529333</ArticleId><ArticleId IdType="pubmed">33024945</ArticleId></ArticleIdList></Reference><Reference><Citation>Swaminathan A, et al. Expression of C9orf72-related dipeptides impairs motor function in a vertebrate model. Hum. Mol. Genet. 2018;27:1754&#x2013;1762. doi: 10.1093/hmg/ddy083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy083</ArticleId><ArticleId IdType="pmc">PMC5932562</ArticleId><ArticleId IdType="pubmed">29528390</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, et al. A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism. Acta Neuropathol. 2018;135:427&#x2013;443. doi: 10.1007/s00401-017-1796-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1796-5</ArticleId><ArticleId IdType="pubmed">29302778</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohki Y, et al. Glycine-alanine dipeptide repeat protein contributes to toxicity in a zebrafish model of C9orf72 associated neurodegeneration. Mol. Neurodegeneration. 2017;12:6. doi: 10.1186/s13024-016-0146-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-016-0146-8</ArticleId><ArticleId IdType="pmc">PMC5237533</ArticleId><ArticleId IdType="pubmed">28088213</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YB, et al. Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic. Cell Rep. 2013;5:1178&#x2013;1186. doi: 10.1016/j.celrep.2013.10.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.10.049</ArticleId><ArticleId IdType="pmc">PMC3898469</ArticleId><ArticleId IdType="pubmed">24290757</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q, et al. Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72. Nat. Neurosci. 2020;23:615&#x2013;624. doi: 10.1038/s41593-020-0619-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0619-5</ArticleId><ArticleId IdType="pmc">PMC7384305</ArticleId><ArticleId IdType="pubmed">32284607</ArticleId></ArticleIdList></Reference><Reference><Citation>Custer KL, Austin NS, Sullivan JM, Bajjalieh SM. Synaptic vesicle protein 2 enhances release probability at quiescent synapses. J. Neurosci. 2006;26:1303&#x2013;1313. doi: 10.1523/JNEUROSCI.2699-05.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2699-05.2006</ArticleId><ArticleId IdType="pmc">PMC6674579</ArticleId><ArticleId IdType="pubmed">16436618</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowder KM, et al. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A) Proc. Natl Acad. Sci. USA. 1999;96:15268&#x2013;15273. doi: 10.1073/pnas.96.26.15268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.26.15268</ArticleId><ArticleId IdType="pmc">PMC24809</ArticleId><ArticleId IdType="pubmed">10611374</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin S, et al. Evidence that C9ORF72 dipeptide repeat proteins associate with U2 snRNP to cause mis-splicing in ALS/FTD patients. Cell Rep. 2017;19:2244&#x2013;2256. doi: 10.1016/j.celrep.2017.05.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.05.056</ArticleId><ArticleId IdType="pmc">PMC5653973</ArticleId><ArticleId IdType="pubmed">28614712</ArticleId></ArticleIdList></Reference><Reference><Citation>Leenders AG, Lopes da Silva FH, Ghijsen WE, Verhage M. Rab3a is involved in transport of synaptic vesicles to the active zone in mouse brain nerve terminals. Mol. Biol. Cell. 2001;12:3095&#x2013;3102. doi: 10.1091/mbc.12.10.3095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.12.10.3095</ArticleId><ArticleId IdType="pmc">PMC60158</ArticleId><ArticleId IdType="pubmed">11598194</ArticleId></ArticleIdList></Reference><Reference><Citation>Binotti, B., Jahn, R. &amp; Chua, J. J. Functions of Rab proteins at presynaptic sites. Cells5, 7 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4810092</ArticleId><ArticleId IdType="pubmed">26861397</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney TR, et al. Regulation of synaptic transmission by RAB-3 and RAB-27 in Caenorhabditis elegans. Mol. Biol. Cell. 2006;17:2617&#x2013;2625. doi: 10.1091/mbc.e05-12-1170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e05-12-1170</ArticleId><ArticleId IdType="pmc">PMC1474797</ArticleId><ArticleId IdType="pubmed">16571673</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannou MS, et al. DENND2B activates Rab13 at the leading edge of migrating cells and promotes metastatic behavior. J. Cell Biol. 2015;208:629&#x2013;648. doi: 10.1083/jcb.201407068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201407068</ArticleId><ArticleId IdType="pmc">PMC4347646</ArticleId><ArticleId IdType="pubmed">25713415</ArticleId></ArticleIdList></Reference><Reference><Citation>Allaire PD, et al. The Connecdenn DENN domain: a GEF for Rab35 mediating cargo-specific exit from early endosomes. Mol. Cell. 2010;37:370&#x2013;382. doi: 10.1016/j.molcel.2009.12.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2009.12.037</ArticleId><ArticleId IdType="pmc">PMC2825348</ArticleId><ArticleId IdType="pubmed">20159556</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerfield, M. The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish Danio (Brachydanio) rerio (Institute of Neuroscience, 1993).</Citation></Reference><Reference><Citation>Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. Stages of embryonic development of the zebrafish. Dev. Dyn. 1995;203:253&#x2013;310. doi: 10.1002/aja.1002030302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/aja.1002030302</ArticleId><ArticleId IdType="pubmed">8589427</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh T, et al. A genetic model of amyotrophic lateral sclerosis in zebrafish displays phenotypic hallmarks of motoneuron disease. Dis. Model Mech. 2010;3:652&#x2013;662. doi: 10.1242/dmm.005538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.005538</ArticleId><ArticleId IdType="pmc">PMC2931540</ArticleId><ArticleId IdType="pubmed">20504969</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>